Quantum Biopharma (QNTM) Competitors $3.89 +0.05 (+1.30%) As of 01/7/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends QNTM vs. COCP, SLGL, MRKR, FBRX, PMN, CMMB, MRNS, CTXR, DARE, and OKURShould you be buying Quantum Biopharma stock or one of its competitors? The main competitors of Quantum Biopharma include Cocrystal Pharma (COCP), Sol-Gel Technologies (SLGL), Marker Therapeutics (MRKR), Forte Biosciences (FBRX), ProMIS Neurosciences (PMN), Chemomab Therapeutics (CMMB), Marinus Pharmaceuticals (MRNS), Citius Pharmaceuticals (CTXR), Daré Bioscience (DARE), and OnKure Therapeutics (OKUR). These companies are all part of the "pharmaceutical preparations" industry. Quantum Biopharma vs. Cocrystal Pharma Sol-Gel Technologies Marker Therapeutics Forte Biosciences ProMIS Neurosciences Chemomab Therapeutics Marinus Pharmaceuticals Citius Pharmaceuticals Daré Bioscience OnKure Therapeutics Cocrystal Pharma (NASDAQ:COCP) and Quantum Biopharma (NASDAQ:QNTM) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership. Do institutionals & insiders hold more shares of COCP or QNTM? 6.7% of Cocrystal Pharma shares are held by institutional investors. Comparatively, 1.2% of Quantum Biopharma shares are held by institutional investors. 25.6% of Cocrystal Pharma shares are held by company insiders. Comparatively, 8.5% of Quantum Biopharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in COCP or QNTM? Cocrystal Pharma received 23 more outperform votes than Quantum Biopharma when rated by MarketBeat users. CompanyUnderperformOutperformCocrystal PharmaOutperform Votes2376.67% Underperform Votes723.33% Quantum BiopharmaN/AN/A Which has stronger valuation & earnings, COCP or QNTM? Cocrystal Pharma is trading at a lower price-to-earnings ratio than Quantum Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCocrystal PharmaN/AN/A-$17.98M-$1.85-1.22Quantum BiopharmaN/AN/A-$17.90M-$15.41-0.25 Is COCP or QNTM more profitable? Quantum Biopharma's return on equity of -84.21% beat Cocrystal Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Cocrystal PharmaN/A -94.62% -78.24% Quantum Biopharma N/A -84.21%-62.63% Does the media prefer COCP or QNTM? In the previous week, Cocrystal Pharma had 3 more articles in the media than Quantum Biopharma. MarketBeat recorded 4 mentions for Cocrystal Pharma and 1 mentions for Quantum Biopharma. Cocrystal Pharma's average media sentiment score of 0.75 beat Quantum Biopharma's score of 0.00 indicating that Cocrystal Pharma is being referred to more favorably in the media. Company Overall Sentiment Cocrystal Pharma Positive Quantum Biopharma Neutral Do analysts recommend COCP or QNTM? Cocrystal Pharma presently has a consensus target price of $7.00, indicating a potential upside of 209.73%. Given Cocrystal Pharma's stronger consensus rating and higher possible upside, equities analysts plainly believe Cocrystal Pharma is more favorable than Quantum Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cocrystal Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Quantum Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, COCP or QNTM? Cocrystal Pharma has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, Quantum Biopharma has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. SummaryCocrystal Pharma beats Quantum Biopharma on 10 of the 14 factors compared between the two stocks. Ad True Market InsidersHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…#1 FREE Crypto for 2025 Get Quantum Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for QNTM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNTM vs. The Competition Export to ExcelMetricQuantum BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.47M$6.63B$5.24B$9.03BDividend YieldN/A2.91%5.30%4.17%P/E Ratio-0.2510.4587.0617.21Price / SalesN/A202.051,085.03141.71Price / CashN/A57.1143.3337.88Price / Book0.185.175.195.13Net Income-$17.90M$153.18M$121.58M$227.03M7 Day Performance5.71%5.41%4.73%3.24%1 Month Performance-8.04%0.34%20.03%4.02%1 Year PerformanceN/A1.96%28.55%18.67% Quantum Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNTMQuantum BiopharmaN/A$3.89+1.3%N/AN/A$7.47MN/A-0.25N/AGap UpCOCPCocrystal Pharma2.9691 of 5 stars$3.05-1.3%$7.00+129.5%+24.5%$31.03MN/A-1.6510High Trading VolumeSLGLSol-Gel Technologies2.7227 of 5 stars$1.11-0.9%$5.00+350.5%+21.8%$30.92M$11.71M-3.2650Gap UpMRKRMarker Therapeutics3.9257 of 5 stars$3.32-4.9%$19.00+472.3%-38.2%$29.63M$3.31M0.0060Gap DownFBRXForte Biosciences2.3311 of 5 stars$20.20-11.9%$23.58+16.7%+62,528.2%$29.53MN/A-1.245PMNProMIS Neurosciences0.8802 of 5 stars$0.90+0.1%N/A-23.2%$29.44M$10,000.00-9.016CMMBChemomab Therapeutics3.1677 of 5 stars$2.04+1.5%$7.50+267.6%+335.5%$29.29MN/A-2.0420MRNSMarinus Pharmaceuticals4.4155 of 5 stars$0.53+42.7%$4.79+803.0%-95.1%$29.25M$31.47M-0.21110Analyst ForecastHigh Trading VolumeCTXRCitius Pharmaceuticals3.1855 of 5 stars$3.89+5.7%$54.50+1,301.0%-77.0%$28.12MN/A-0.6520Analyst ForecastNews CoverageHigh Trading VolumeDAREDaré Bioscience1.8077 of 5 stars$3.19-2.4%$24.00+652.4%-21.8%$27.75M$1.88M-5.4030Positive NewsOKUROnKure Therapeutics3.5403 of 5 stars$8.21+0.6%$36.00+338.5%N/A$27.45MN/A-0.67N/AHigh Trading Volume Related Companies and Tools Related Companies Cocrystal Pharma Alternatives Sol-Gel Technologies Alternatives Marker Therapeutics Alternatives Forte Biosciences Alternatives ProMIS Neurosciences Alternatives Chemomab Therapeutics Alternatives Marinus Pharmaceuticals Alternatives Citius Pharmaceuticals Alternatives Daré Bioscience Alternatives OnKure Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:QNTM) was last updated on 1/8/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDonald Trump to Repeal Executive Order #14110?Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quantum Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quantum Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QNTM Stock Alerts